Understanding The Potential Applications of R-Ras2 (G22800)

Target Name: RRAS2

NCBI ID: G22800

RRAS2

Understanding The Potential Applications of R-Ras2

Ras-related protein R-Ras2 (isoform a) is a protein that is highly expressed in various tissues, including the brain, and is involved in several cellular processes. Its function is crucial in the regulation of cell signaling pathways, and it has been implicated in the development and progression of several diseases, including cancer. As a result, R-Ras2 has emerged as a promising drug target and biomarker for a variety of diseases.

The R-Ras2 protein is a member of the RAS gene family, which is known for its role in cell signaling pathways. The RAS gene family consists of four isoforms, A, B, C, and D, which encode different isoforms of the RAS protein. R-Ras2 is one of the isoforms, and it is highly expressed in various tissues, including the brain, heart, and gastrointestinal tract.

The functions of R-Ras2 are numerous and varied. It plays a role in the regulation of cell signaling pathways, including the G-protein-coupled receptor (GPCR) signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. R-Ras2 is also involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation and immune responses.

In addition to its role in cell signaling pathways, R-Ras2 is also implicated in the development and progression of several diseases. For example, R-Ras2 has been implicated in the development of cancer, due to its involvement in the regulation of cell signaling pathways that are often disrupted in cancer cells. Additionally, R-Ras2 has been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, due to its involvement in the regulation of cellular processes that are often disrupted in these conditions.

As a result of its involvement in these processes, R-Ras2 has emerged as a promising drug target and biomarker for a variety of diseases. For example, researchers have been investigating the use of drugs that can inhibit R-Ras2 activity in order to treat a variety of conditions, including cancer, neurodegenerative diseases, and chronic pain. Additionally, researchers have been investigating the use of R-Ras2 as a biomarker for the diagnosis and monitoring of disease outcomes, such as cancer recurrence and treatment effectiveness.

In conclusion, R-Ras2 is a protein that is involved in the regulation of cell signaling pathways and has been implicated in the development and progression of several diseases. As a result, it has emerged as a promising drug target and biomarker for a variety of conditions. Further research is needed to fully understand the functions of R-Ras2 and its potential as a drug and biomarker.

Protein Name: RAS Related 2

Functions: GTP-binding protein with GTPase activity involved in the regulation of MAPK signaling pathway, thereby controlling multiple cellular processes (PubMed:31130282). Involved in the regulation of MAPK signaling pathway (PubMed:31130282, PubMed:31130285). Regulation of craniofacial development (PubMed:31130282, PubMed:31130285)

The "RRAS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RRAS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets